Agoranov

Agoranov is a public science and technology incubator located in Paris, France, established in 2000. It focuses on nurturing startups in various sectors, including industry, greentech, digital technology, and health. Agoranov offers a comprehensive support system that includes mentorship, office space, funding, and consultancy services. Having assisted over 380 startups, the incubator has facilitated the creation of more than 7,000 direct jobs and helped these companies raise €700 million from private investments. Notable startups supported by Agoranov include Criteo, Anevia, Biophytis, Gensight, Pixium, Aldebaran, Dataiku, Doctolib, Point Vision, and Ynsect. Founded by a consortium of prestigious institutions, Agoranov is backed by various governmental and regional organizations, providing its incubated companies with personalized support, a robust acceleration program, high-quality facilities in central Paris, and access to a vibrant community of entrepreneurs.

Jean-Michel Dalle

Director

Past deals in France

Pimento

Non Equity Assistance in 2023
Pimento is an information technology company based in Paris, France, that specializes in enhancing human creativity through its artificial intelligence-powered platform. Established in 2022, Pimento focuses on streamlining the creative process by utilizing generative AI to facilitate activities such as brainstorming and mood boarding. The company's bespoke engines leverage proprietary data to generate content that aligns with users' unique styles, allowing for efficient and innovative creative iterations. This approach empowers ambitious creatives to transform briefs into impactful creative directions, fostering an environment conducive to bold and daring projects.

Differs

Non Equity Assistance in 2023
Differs, established in 2023 and headquartered in Paris, France, is a software development company that empowers retailers to maximize profits and attract customers through AI-driven solutions. Their flagship product, Discount, leverages advanced price elasticity AI to analyze past promotions and provide optimal discount strategies, enabling businesses to be proactive and enhance their revenue.

Upfund

Non Equity Assistance in 2023
Upfund, established in 2022 and headquartered in Paris, France, is a real estate technology company specializing in commercial property data. It offers a digital platform that aggregates and qualifies data to streamline market analysis, providing insights on transactions, foot traffic, and tenants. This enables clients, such as brokers, investors, and lenders, to generate reports, identify suitable locations, and stay informed about market trends.

Orosound

Private Equity Round in 2023
Orosound is a French startup focused on enhancing workplace well-being through innovative Noise Control Technologies. The company designs and manufactures high-tech audio earphones under the brand Tilde, which feature advanced noise-filtering technology. This technology allows users, particularly office workers, to selectively filter out distracting ambient noise, thereby improving concentration and productivity in their work environments. Orosound's commitment to developing acoustic products aims to enhance the daily lives of individuals by providing effective solutions for noise management.

Spore Biotechnologies

Non Equity Assistance in 2023
Spore Biotechnologies is a manufacturing company that develops innovative technological tools to help factories manufacture safe products. Spore Biotechnologies are developing new weapons to fight climate change, globalization, new consuming habits, bacterial resistance, and microbiological scandals. Founded by Amine Raji and Maxime Mistretta in 2022 and is located in Paris, France.

Pepkon

Non Equity Assistance in 2023
Pepkon is a biotechnology company based in Paris, France, focused on developing innovative peptides for the treatment of difficult-to-treat cancers, including various leukemias and solid tumors. Established in 2022 by Philippe Karoyan, Jean Pascal Tranié, and Patric Weil, Pepkon aims to advance its lead product, PKT16, into clinical trials, with a particular emphasis on Chronic Lymphocytic Leukemia (CLL) as its initial target. The company's approach is grounded in the design of small peptides that mimic the C-terminal domain of Thrombospondin-1, offering a promising new avenue for cancer therapy. Pepkon also engages in academic research and scientific publications, contributing to the broader understanding of cancer treatment and aiming to enhance safety and efficacy for healthcare professionals.

Persea

Non Equity Assistance in 2023
Persea is a biotechnology research company that developing a game-changing treatment against liver cancers called BioTrojan. Persea is a French biotechnology start-up that innovates Advanced Therapy Medical Products (ATMP) composed of allogeneic mesenchymal stem cells. Their treatment is called BioTrojan in reference to the Trojan horse: it is in short a cellular Trojan horse carrying a suicide gene which, once introduced into the tumor, reacts on contact with the cyclophosphamide acting as the messenger. Founded in 2021 and is located in Paris, France.

Amatera

Non Equity Assistance in 2023
Amatera is a biotechnology research company based in Paris, France, founded in 2022 by Omar Dekkiche and Lucie Kriegshauser. The company focuses on developing sustainable and climate-resistant coffee varieties using advanced biotechnology techniques. By leveraging non-genetically modified organism (GMO) technology, Amatera aims to create a naturally caffeine-free coffee variety that eliminates the need for decaffeination, thereby reducing both financial and environmental costs while preserving flavor integrity. Through its innovative approach, Amatera seeks to address the growing demand for cleaner and greener coffee options in the market.

Akuity Care

Non Equity Assistance in 2023
Akuity Care is a software development company based in Paris, France, founded by Grégory Lista and Adrian Ahne in 2022. The company specializes in AI-powered vocal biomarkers to enhance the management of chronic diseases. By analyzing voice samples, Akuity Care's platform monitors disease progression, evaluates symptoms and side effects, and provides guidance for treatment decisions. This approach aims to make healthcare more decentralized, responsive, and personalized, allowing patients and healthcare providers to take a proactive stance in managing chronic conditions.

Astran

Non Equity Assistance in 2022
Astran is a software development company that unlocks cloud adoption without compromising data confidentiality, security, and compliance. Astran is a zero-trust cloud-native platform that runs on multiple cloud providers. They connect preferred cloud providers, configure distributed data vaults, and switch cloud providers just as easily whenever they need. Founded by Yosra Jarraya in 2021 and is located in Paris, Île-de-France.

Orakl

Non Equity Assistance in 2022
Orakl is a biotechnology company that concerns with cancer treatment and drug development. Orakl enables the emergence of rare oncology by connecting patient tumors to the drug discovery industry. Orakl leverages tumor avatars that combine best-in-class biology with deep patient data, at scale. Their tech bio platform partners with oncology players to identify relevant targets and deliver better drugs, faster. Founded by Fanny Jaulin, Diane-Laure Pagès, and Gustave Ronteix and is located in Villejuif, France.

Nopillo

Non Equity Assistance in 2022
Nopillo is a Paris-based company founded in 2022 that specializes in providing tools designed to automate and optimize tax declarations and return on investment for property owners. The company operates a rental management platform that assists landlords with administrative management and accounting tasks. Its offerings include a tax simulator, accounting software, and tools for generating lease contracts and recipes. By streamlining these processes, Nopillo aims to simplify the administrative and accounting responsibilities of property owners, allowing them to focus on overall performance and cost management.

Datapolitics

Non Equity Assistance in 2022
Datapolitics is a Paris-based company founded in 2021 that provides data decryption and advocacy services tailored for media and public affairs professionals. The platform enables politicians to effectively communicate and engage with their constituents by analyzing political discourse and generating original content. Datapolitics offers tools such as mappings, alerts, and analyses to assist clients in understanding complex political landscapes. By leveraging data-driven insights, the company delivers actionable recommendations to support strategic advocacy efforts and informed public decision-making.

BMTA&C

Non Equity Assistance in 2022
BMTA&C, established in 2019 and headquartered in Paris, France, specializes in innovative off-grid refrigeration technology. The company develops solutions to preserve perishables in challenging environments, where traditional methods are inadequate. Their technology harnesses thermal energy, allowing clients to operate in diverse weather conditions and geographical locations.

Carboneo

Non Equity Assistance in 2022
Carboneo is a Paris-based company founded in 2020 that specializes in recycling services aimed at transforming carbon dioxide into valuable raw materials. Utilizing power generated from renewable sources, Carboneo converts carbon dioxide into carbon monoxide and dioxygen. This innovative process supports chemical manufacturing industries by enabling them to reduce their greenhouse gas emissions and overall carbon footprints, contributing to more sustainable practices in the sector.

Qatent

Non Equity Assistance in 2022
Qatent is a Paris-based company founded in 2021 that specializes in developing artificial intelligence-driven software for intellectual property (IP) professionals. The company’s patent drafting software is designed to streamline the patent creation process by offering tools such as claim-writing capabilities, generation options, a description editor, and patent filing features. By leveraging AI technology, Qatent aims to assist IP experts in drafting accurate patents more efficiently, ultimately enhancing the effectiveness of IP services.

Metyos

Non Equity Assistance in 2022
Metyos is a Paris-based company specializing in wearable biosensor technology that monitors the effects of daily activities on nutrition and metabolism. By analyzing users' day-to-day data, including fat levels and energy metabolism dynamics, Metyos provides personalized fitness and nutrition routines. The company's aim is to help individuals understand how their bodies respond to their actions, thereby empowering them to achieve their weight goals and regain control over their health.

AUSTRAL Dx

Non Equity Assistance in 2021
AUSTRAL Dx, founded in 2021 and based in Paris, is a medical device company focused on enhancing the screening, diagnosis, and monitoring of cardiac and pulmonary conditions. The company is pioneering a novel imaging technique that utilizes airborne ultrasound technology to capture vibrations from the lungs. This innovative approach is designed for use in emergency services, allowing healthcare professionals to expedite the diagnosis of patients experiencing symptoms like dyspnea or chest pain. By improving the accuracy and speed of diagnoses, AUSTRAL Dx aims to enhance the management and follow-up of lung and cardiac diseases, addressing both acute and chronic patient needs.

Simbel

Non Equity Assistance in 2021
Simbel is an edtech company founded in 2021 and based in Paris, France, that focuses on facilitating learning and development for small and medium-sized businesses. The company offers a software-as-a-service (SaaS) platform that serves as a marketplace for training, connecting employees with curated training providers and a variety of courses tailored to their development needs. By integrating with existing HR systems, Simbel begins with performance reviews to identify individual learning requirements, promoting a culture of continuous improvement. The platform streamlines learning and development workflows, enhances employee engagement, and helps optimize training budgets, ultimately transforming organizations into environments that prioritize growth and skill enhancement.

Kinetix

Non Equity Assistance in 2021
Kinetix is a company founded in 2020 and based in Paris, France, that focuses on empowering self-expression in the Metaverse through artificial intelligence and no-code tools. It provides solutions that enable users to easily create 3D animations, making this technology accessible to a broader audience. Kinetix leverages advancements in AI to streamline the animation process, allowing individuals without technical expertise to engage in creative activities within virtual environments. Its mission centers on democratizing the creation of digital content, contributing to the evolving landscape of the Metaverse and enhancing the ways in which users can communicate and express themselves digitally.

Umiami

Non Equity Assistance in 2021
Umiami is a French food-tech startup founded in 2020 and based in Paris, specializing in plant-based food technology aimed at reducing meat consumption. The company develops innovative plant-based whole-cuts that utilize plant proteins to create alternatives that closely mimic the taste, texture, and aroma of traditional meat products. Through its technological advancements, Umiami seeks to provide consumers with sustainable and appealing food options that align with growing dietary preferences towards plant-based diets.

Core Biogenesis

Non Equity Assistance in 2020
Core Biogenesis is a biotechnology company based in Paris, France, founded in 2020. It specializes in developing next-generation recombinant protein production technologies that utilize proprietary gene editing and plant biotechnology. The company aims to significantly lower the cost of producing growth factors, which are essential molecules used in the clean meat and cell therapy industries. Core Biogenesis employs an ultra-scalable bioproduction as a service (UBaaS) platform, allowing for the efficient mass production of valuable bioproducts by using plants as biofactories. This innovative approach enhances the speed and scalability of molecule extraction while enabling clients in the healthcare sector to improve cell growth, division, and survival, ultimately increasing yields and reducing costs.

Hummink

Non Equity Assistance in 2020
Hummink is a company specializing in additive manufacturing technology, focusing on nano-printing solutions that enable precise design and manufacturing at the nanoscale. Founded in 2020 in Paris by Amin M'barki, Pascal Boncenne, Lydéric Bocquet, Alessandro Siria, and Antoine Nigues, Hummink utilizes a patented technology that integrates a nanometric pen with an oscillating microresonator. This innovative approach allows for the capillary deposition of various liquids, equipping clients in the semiconductor and molecular diagnostic industries with the capability to create large objects while maintaining exceptional resolution and precision on substrates ranging from millimetric to centimetric scales.

Samp

Non Equity Assistance in 2020
Samp is a French company founded in 2019 by Laurent Bourgouin and Shivani Shah in Paris. It specializes in developing software that consolidates technical information into Digital Twins, providing a comprehensive and accurate 3D model of industrial plants. Samp's offerings include Digital Twin as a Service, which uses machine learning to integrate 3D laser scans and technical data from various sources into an intelligent web portal. Additionally, the company provides As-Built automatic verification, utilizing advanced algorithms to compare laser scans with 3D CAD models, highlighting any discrepancies that need attention. This technology enables engineers and site workers to efficiently verify the actual state of facilities against initial design models, saving significant time and effort.

Omny Cloud

Non Equity Assistance in 2020
Omny Cloud provides virtual desktops and networks using a cloud platform that is scalable across multiple deployment options. Félix Perreau and Augustin Gaillot co-founded the company in Paris, Ile-de-France, France in 2019.

Circul'Egg

Non Equity Assistance in 2020
Circul'Egg is a Paris-based company that specializes in recycling eggshells to create two primary products: calcium carbonate powder and shell membrane powder. By transforming waste from the egg industry, Circul'Egg contributes to the circular economy, promoting sustainable practices in various sectors. Its products cater to the animal feed market, including pet food and feed for farm animals, as well as the nutraceutical and cosmetic industries. The company focuses on providing natural, biobased, and eco-designed solutions that are rich in minerals and beneficial biomolecules, addressing the needs of manufacturers seeking sustainable and nutritious ingredients.

One Biosciences

Non Equity Assistance in 2020
One Biosciences, headquartered in Paris, France, specializes in precision medicine for cancer care. It employs single-cell technologies and AI-driven analysis of clinical specimens to deconvolute complex biological data. The company aims to improve patient selection, facilitate the development of novel therapies, optimize treatment strategies, and connect patients to relevant clinical trials.

C12 Quantum Electronics

Non Equity Assistance in 2020
C12 Quantum Electronics is a company based in Paris, Ile-de-France, France, founded in 2019 by Pierre and Matthieu Desjardins. The company focuses on developing reliable quantum processors utilizing carbon nanotubes, which significantly reduce error rates. This technology positions C12 Quantum Electronics as a strong candidate for noisy intermediate-scale quantum applications. In addition to building quantum computers, the company also engages in developing and accelerating experiments related to information processing systems, allowing industrial clients to leverage intermediate-scale quantum applications for enhanced computing capabilities.

MadeCell

Non Equity Assistance in 2020
MadeCell is a French technology company specializing in integrated management software for the production and quality control of innovative therapeutic drugs, including cell, gene, and tissue therapies. Headquartered in Bois-Colombes, Ile-de-France, France, the company was founded by Eric Hanesse, André Desproges, Lionel Faivre, and Hélène Boucher. MadeCell's software solutions focus on improving manufacturing processes and traceability to enhance the quality of advanced medical products.

Lynceus

Non Equity Assistance in 2020
Lynceus is a company that specializes in AI and machine learning solutions aimed at enhancing quality control in complex manufacturing processes. Founded by David Meyer and Guglielmo Montone in Paris, the company develops software that predicts the outcomes of quality tests in real-time, allowing manufacturers to identify potential defects and monitor machine performance effectively. By leveraging advanced algorithms, Lynceus enables clients to anticipate quality issues before they occur, facilitating timely adjustments to production processes. This proactive approach not only improves product quality but also leads to significant cost savings for manufacturers.

Sarus Technologies

Non Equity Assistance in 2020
Sarus Technologies SAS is a privacy-tech company based in Paris, France, established in 2019. It specializes in developing software that allows data scientists and business analysts to perform analytics on sensitive data without direct access to that data. By implementing differential privacy, Sarus enables users to work with personal data while ensuring that their analyses do not embed any identifiable information. This approach makes traditional anonymization methods obsolete, significantly reducing the time and effort required for compliance and data engineering. Sarus's solutions facilitate collaboration on sensitive data across different business units, regions, and external partners, eliminating confidentiality risks and allowing data practitioners to leverage the full value of data while maintaining the highest standards of privacy.

Extrality

Non Equity Assistance in 2020
Extrality is a technology company based in Paris, Ile-de-France, France, founded in 2019. It specializes in developing a platform that utilizes machine learning to provide rapid numerical simulations. This platform is designed to simplify the process of conducting artificial intelligence-powered simulations, enabling engineers to quickly assess critical parameters such as aerodynamics, fluid dynamics, and thermal properties of products. By maintaining high levels of physical accuracy, Extrality's solutions help manufacturers in industries such as aerospace, transport, and energy significantly reduce their time-to-market, enhancing efficiency and innovation in product development.

Dry4Good

Non Equity Assistance in 2020
Dry4Good is a food production company based in Paris, Ile-de-France, France, that specializes in the dehydration of foods to maintain their nutritional values and organoleptic qualities. Founded in 2019 by Jean-Gabriel Dijoud and Romaric Janssen, the company aims to promote healthy and natural food production. By utilizing advanced dehydration techniques, Dry4Good provides high-quality finished products that cater to food professionals, industrialists, and independent businesses. The company focuses on restoring the naturalness of ingredients in the manufacturing process, ensuring that its offerings meet the needs of a growing market that values health-conscious and quality food options.

Hillo

Seed Round in 2020
Hillo is a company based in Palaiseau, France, founded in 2016, that specializes in the design and development of an artificial intelligence platform aimed at transforming the lives of diabetic patients. It creates tools for continuous blood glucose monitoring, offering a diabetes management platform that provides real-time glycemia predictions and personalized treatment suggestions. The software is designed to adapt to individual patients, synchronizing with insulin delivery devices, logging treatment history, assessing meal intake, and learning from behavioral and physiological responses. Through these innovations, Hillo aims to enhance diabetes management and improve health outcomes for patients.

Bioadhesive Ophthalmics

Non Equity Assistance in 2020
Bioadhesive Ophthalmics is a developer of a pharmaceutical platform that aims to transform ophthalmology by relieving patients from the burden of their eye diseases. The company's pharmaceutical technology includes a mucoadhesive ocular hydrogel insert that releases a therapeutic molecule medicinal substances to the eye continuously over a period of a week, thus enhancing the impact of treatment, enabling the eye patients to get ease from the complexity of frequent eye drop application by generating a continuous and controlled sustained hydrogel release. It was founded in Orsay, Ile-de-France, France by Jean Garrec and Jean Cuiné in 2020.

Modjo

Non Equity Assistance in 2020
Modjo is a conversation intelligence platform based in Paris, France, founded in 2019 by Matthieu de la Fournière, Paul Berloty, and Como Hug de Larauze. The company specializes in cloud-based software that captures and analyzes customer interactions, providing valuable insights that empower revenue teams to make informed decisions. By utilizing conversational analytics, Modjo enhances sales team performance, enabling them to convert opportunities more effectively. The platform focuses on optimizing the decision-making process through data-driven insights rather than reliance on opinions.

Codist AI

Non Equity Assistance in 2020
Codist AI is an artificial intelligence-based platform that specializes in code management services. Established in 2019 by Maeliza Seymour and Shubhadeep Roychowdhury in Paris, the company offers automated documentation of source code, which enhances code quality and streamlines the coding process. This service facilitates quicker onboarding for developers, allowing them to analyze and comprehend code more effectively. By focusing on improving the overall coding experience, Codist AI aims to make software development more efficient.

ImVitro

Non Equity Assistance in 2019
ImVitro is a medical device developer based in Paris, France, founded by Alexandra Boussommier Calleja and Maryame Boulhajat in 2019. The company specializes in creating AI-based tools for in vitro fertilization (IVF) decision-making. ImVitro's platform uses deep learning algorithms to analyze various clinical inputs, identifying patterns that predict which embryo has the highest chance of successful implantation. This technology aims to reduce the number of IVF cycles patients need to undergo and enhance the efficiency of IVF clinics.

BCDiploma

Non Equity Assistance in 2019
BCDiploma is a Paris-based company established in 2017 that specializes in developing applications for higher education institutions and their graduates. The company focuses on the dematerialization and automation of certified diploma and certificate issuance, leveraging blockchain technology to ensure high security and reliability. Its flagship product, EvidenZ, enables institutions to create on-chain registers for various data types, including diplomas, while adhering to data privacy regulations. BCDiploma’s platform utilizes an encryption algorithm and the Ethereum blockchain to safeguard data, making it accessible solely through a secure URL provided to the certificate holder. This innovative solution enhances the digital experience and professional mobility of learners by streamlining institutional processes and providing secure, easily accessible credentials.

Locomotive

Non Equity Assistance in 2019
Locomotive, headquartered in Paris, France, is a SaaS platform established in 2019 that provides messaging tools specifically designed for local businesses. The platform aims to enhance the operational efficiency of its clients by facilitating the establishment of repeatable commercial processes. By leveraging the widespread use of smartphones, Locomotive offers local businesses a competitive edge, allowing them to improve their productivity and streamline communication with customers.

SheeldMarket

Non Equity Assistance in 2019
SheeldMarket is a cryptocurrency trading platform intended to keep the positions of the market participants hidden. The company's product uses an encryption scheme that allows the low-latency exchange of assets in order to protect user interests with chip encryption and predatory behavior prevention algorithms, thereby enabling market participants to trade large blocks of assets without alpha leakage. It was founded in 2019 in Paris, Ile-de-France, France by Oliver Yates, Simon Douyer, and Arnaud Carrere.

Epigene Labs

Non Equity Assistance in 2019
Epigene Labs SAS is a biotechnology firm focused on enhancing precision oncology through its advanced technology platform that utilizes artificial intelligence. Founded in 2019 and headquartered in Paris, France, with an additional office in Boston, Massachusetts, the company addresses the significant challenges of aggregating, analyzing, and visualizing extensive genomic data in cancer research. By integrating proprietary data from partners with publicly available datasets, Epigene Labs provides medical researchers with actionable insights and user-friendly analytics. The company collaborates with leading cancer centers and prominent biotech firms to develop intelligence-augmenting services that support drug discovery and research in precision oncology. Its innovative approach aims to transform genomic data into effective strategies for targeted cancer therapies.

CryptoNext

Non Equity Assistance in 2019
CryptoNext, established in 2018 and headquartered in Paris, France, specializes in developing advanced security software. The company focuses on protecting data from future quantum threats by offering an application for secure document exchange using quantum-safe cryptography. Additionally, CryptoNext provides a cryptographic library with quantum-safe signature and key-exchange functionalities, along with consulting services to assist clients in transitioning to quantum-safe cryptography. Born as a spin-off from Inria Paris and Sorbonne University, CryptoNext aims to mitigate the serious security risks posed by large-scale quantum computers to electronic communications.

Adakazam

Non Equity Assistance in 2019
Adakazam is a Paris-based company, incorporated in 2018, specializing in the automation and optimization of advertising on Amazon. As a subsidiary of Magellan RMT SAS, Adakazam develops a software-as-a-service (SaaS) platform designed specifically for managing Amazon ad campaigns. Its flagship product, the Pay-Per-Click Wizard, utilizes machine learning algorithms to streamline the management of sponsored product campaigns. This platform offers multi-language support, allowing businesses to tailor their advertising strategies effectively and enhance their sales performance on Amazon.

Harold Waste

Non Equity Assistance in 2019
Harold Waste SAS is a software development company focused on delivering innovative solutions for recycling companies. Established in 2018 and headquartered in Saint-Ouen, France, Harold Waste aims to assist stakeholders in the waste management sector by providing tools that enhance their operations. The company distinguishes itself by not positioning itself as a platform or seeking to disrupt existing services in the industry. Instead, Harold Waste is dedicated to supporting current participants in the waste management ecosystem, fostering more efficient and effective recycling processes.

Braintale

Non Equity Assistance in 2019
Braintale is a Paris-based company founded in 2018 that specializes in developing and distributing innovative diagnostic and prognostic tools specifically for brain-injured patients. The company's digital medical care platform is designed for hospitals to effectively analyze MRI reports, providing accessible solutions that meet the needs of healthcare professionals and patients alike. Braintale’s products are grounded in over 15 years of clinical development, focusing on predicting patient outcomes, particularly for those in comas due to severe traumatic brain injuries, cardiac arrests, or hemorrhagic strokes. By facilitating easier diagnoses, Braintale aims to enhance patient care in critical settings, ultimately improving the prognosis for individuals with severe brain injuries.

Veesion

Non Equity Assistance in 2018
Veesion is a technology company specializing in gesture recognition for real-time detection of shoplifting within the retail sector. Founded in 2018 and based in Paris, France, Veesion utilizes deep learning algorithms to analyze footage from security cameras, identifying gestures indicative of theft. The system autonomously generates alerts that are sent to human operators for confirmation and subsequent action. This innovative software can be integrated with existing surveillance systems, allowing retailers and distributors to enhance their security measures while optimizing the allocation of security personnel. By providing an ethical and effective solution to combat shoplifting, Veesion is reshaping the standards of retail security.

Siteflow

Non Equity Assistance in 2018
Siteflow is a Paris-based company founded in 2017 that specializes in developing cloud-based service management software tailored to the complexities of regulated industries such as nuclear, manufacturing, special works, and oil and gas. Its primary product, Siteflow Builder, facilitates the organization and execution of operations, enabling real-time project tracking and performance assessment. The software aims to enhance daily operations and collaboration among teams while standardizing workflows in environments where traditional tools have remained largely unchanged. Siteflow addresses the challenges of digital transformation by creating user-friendly interfaces and functionalities that streamline tasks for engineers, project managers, and field operators. The company also supports organizations in implementing change management programs to ensure a smooth transition to operational excellence, ultimately enhancing quality and safety standards in complicated industry settings.

Ganymed Robotics

Non Equity Assistance in 2018
Ganymed Robotics SAS, established in 2018 and headquartered in Paris, France, specializes in the development of advanced robotics technologies tailored for orthopedic surgeons. The company's primary focus is on creating a therapeutic device designed to enhance surgical precision during knee replacement procedures. This innovative technology aims to improve patient outcomes, surgeon experience, and overall efficiency of care delivery by leveraging robotic assistance to reduce operating time.

Iktos

Non Equity Assistance in 2018
Iktos is a French scale-up company focused on applying artificial intelligence and robotic technologies to medicinal chemistry and drug design. The company has developed a proprietary generative AI solution that optimizes small molecules in silico, enhancing productivity in pharmaceutical research and development. Iktos offers its expertise through its SaaS platforms, Makya™ for generative drug design and Spaya™ for retrosynthesis, while also collaborating with pharmaceutical companies to accelerate drug discovery processes. Additionally, Iktos has created Iktos Robotics, an AI-driven automation platform that significantly speeds up the Design-Make-Test-Analyze cycle in drug discovery. The company is also advancing its own pipeline of drug candidates aimed at oncology and autoimmune diseases. In 2023, Iktos completed a significant financing round and, in 2024, expanded its capabilities through the acquisition of Synsight, integrating a biology platform focused on discovering new drugs that target Protein-Protein Interactions and RNA-Protein Interactions.

Blacknut

Non Equity Assistance in 2017
Blacknut is a leading cloud gaming service that focuses on providing a subscription-based platform for video games to a broad audience. Founded in 2016 by Olivier Avaro and headquartered in Rennes, France, with additional offices in Paris, Seoul, and San Francisco, Blacknut offers over 400 premium titles suitable for all ages. The service is accessible across various devices, including mobile phones, set-top boxes, and Smart TVs, and is available in Europe, Asia, and North America. Blacknut's platform employs an algorithm that tailors game recommendations based on user preferences, ensuring easy and immediate access to a diverse catalog of games. This approach fosters community engagement, allowing players to discover new games and share experiences in real time.

Lalilo

Venture Round in 2017
Lalilo is a Paris-based company founded in 2016 that specializes in developing web-based application software for K-2 teachers. The platform leverages artificial intelligence to create customized reading exercises tailored to each student's individual needs. It also prepares personalized printable worksheets, enhancing the learning experience. Lalilo aims to revolutionize literacy education by empowering teachers to differentiate instruction and support varied learning paces within the classroom. The application is accessible on multiple devices, including tablets and computers, making it versatile for educational settings. Through its innovative approach, Lalilo seeks to improve reading skills among young learners while facilitating effective teaching strategies.

Agriloops

Seed Round in 2017
Agriloops is a company based in Paris, France, founded in 2016, that specializes in aquaponic farming in salt water. The company focuses on reinventing aquaculture to produce eco-friendly and healthier food products, primarily shrimp and vegetables. Agriloops designs innovative aquaponic production systems that promote sustainable agricultural practices. By utilizing salt water, the company aims to enhance the flavor and quality of its produce while contributing to environmentally responsible farming methods. Agriloops is dedicated to providing fresh and natural food options, thereby addressing the growing demand for sustainable seafood and vegetables.

Tilkal

Venture Round in 2017
Tilkal is a Paris-based company founded in 2017 that specializes in supply chain traceability and trust solutions for Industry 4.0. The company has developed a software infrastructure that organizes traceability data across various supply chain stakeholders, utilizing a unique B2B blockchain network to facilitate secure and verifiable data sharing. Tilkal's platform incorporates analytics and scoring algorithms to provide an end-to-end, real-time representation of supply chains. This enables businesses to address critical questions regarding product location, sourcing risks, ESG commitments, and compliance verification. Prominent clients include Danone, Daher, Joone, and the NGO Responsible Mica Initiative, which leverage Tilkal's capabilities for diverse applications such as tracing infant milk sourcing and analyzing mica supply chains. The Tilkal network comprises over 70 independent nodes and serves nearly 700 companies, reinforcing its role in promoting resilience, sustainability, and ethical practices within supply chains.

Cycle Farms

Venture Round in 2017
Cycle Farms is a company based in Massy, France, that specializes in producing fish feed and compost through innovative bioconversion processes. Established in 2016, Cycle Farms operates a vertically integrated feed mill that converts biowaste into high-quality insect proteins. These proteins are used to create floating pellets specifically designed for fish farmers in West Africa. In addition to fish feed, Cycle Farms also provides compost for organic farming, promoting sustainable agricultural practices. By leveraging biowaste, the company not only enhances the nutritional value of animal feed but also supports environmental sustainability and cost savings for its clients.

WIT France

Venture Round in 2016
WIT France SAS, established in 2006 and headquartered in Blanquefort near Bordeaux, specializes in manufacturing glass tube containers designed for the storage and presentation of wines and spirits in individual formats. Founded by an oenologist and a sommelier, the company leverages several technological innovations to ensure that its products maintain the quality and preservation of traditional bottles while catering to the needs of both professionals and consumers. WIT France's offerings are utilized in various commercial sectors, including showrooms, wine shops, trade shows, hotels, and restaurants, and serve marketing purposes for importers, salesmen, and corporate gifts. The company operates both nationally and internationally, providing a unique packaging solution for the wine industry.

Antescofo

Venture Round in 2016
Antescofo SAS is a French company that specializes in developing artificial intelligence-based applications for musicians, singers, and music students. Established in 2016 and headquartered in Gentilly, the company offers a platform that functions as a virtual orchestra, enhancing the performance experience for its users. The technology behind Antescofo is the culmination of over seven years of research and development at IRCAM, the world's largest laboratory dedicated to the intersection of music and technology. By utilizing intelligent machine listening, the platform recognizes real-time musical performances, allowing for synchronization of content and creating an immersive experience for musicians and performers.

Scortex

Venture Round in 2016
Scortex is a Paris-based company founded in 2016 that specializes in intelligent automation for quality control within the manufacturing industry. It has developed a Quality Intelligence Platform that leverages artificial intelligence to enhance visual inspections and provide real-time analytics on production and quality issues. The platform is designed for large manufacturers in sectors such as automotive, fast-moving consumer goods, and medical devices. By automating defect detection and analytics, Scortex significantly reduces the cost of quality while improving operational efficiency, machine maintenance, and product quality. Its solutions aim to transform traditional quality inspection processes, enabling manufacturers to achieve better production outcomes and profitability.

Otherwise

Venture Round in 2016
Otherwise is a pioneering collaborative insurance broker based in France, focusing on providing peer-to-peer insurance solutions. The company creates a platform that connects individuals with shared insurance needs, allowing them to pool resources for better coverage and cost efficiency. By leveraging behavioral analysis alongside community management and machine learning, Otherwise facilitates a significant reduction in overall insurance costs for its members. Additionally, the platform offers tailored animal insurance services, featuring transparent pricing models that accommodate individual budgets. These services include veterinary assistance and collaborative bonuses, enabling policyholders to seamlessly manage benefits through compulsory plans and advance cost options.

Auxivia

Venture Round in 2016
Auxivia, established in 2015 and headquartered in Paris, France, specializes in designing and developing smart glasses connected to an online platform. These glasses, indistinguishable from regular ones, track water intake and alert users to prevent dehydration. The company's innovative solution aims to enhance caregiving quality for elderly individuals, particularly those with declining autonomy, by enabling caregivers to monitor and manage their water intake effectively.

Concilio

Venture Round in 2016
Concilio is a digital health platform headquartered in Paris, France, focused on enhancing access to healthcare and preventive services. The company develops a healthcare service platform that assesses and improves personal health by providing tailored healthcare recommendations and medical consultations. Users benefit from personalized insights and can connect with appropriate healthcare professionals for curated advice. Concilio aims to deliver reliable health information, facilitating quick access to specialists suited to individual health needs.

Neurallys

Venture Round in 2016
Neurallys is a Paris-based company that specializes in developing and producing medical devices focused on neurology and neurosurgery. The company has created an intelligent sensor that communicates with a smartphone to monitor intracranial pressure in patients suffering from hydrocephalus. This innovative device aims to enhance patient comfort and provides neurosurgeons with an effective tool for monitoring and managing the condition. By facilitating better follow-up care, Neurallys' technology seeks to improve the overall quality of treatment for individuals affected by this pathology.

Stanley Robotics

Venture Round in 2015
Stanley Robotics SAS, founded in 2015 and based in Paris, France, specializes in the design and development of autonomous valet parking robots. The company offers a unique parking solution that enhances the experience for travelers at airports. Users simply drop off their vehicles at a secure, well-lit parking cabin and provide their booking and flight information. The company's robotic valet, named Stan, autonomously retrieves the vehicle and parks it in an available spot, eliminating the hassle of searching for parking. Stan is also connected to flight schedules, ensuring that cars are ready for retrieval upon the travelers' return. This innovative approach prioritizes efficiency and security, providing a streamlined experience that includes user-friendly kiosks for booking and adaptations for individuals with reduced mobility. By minimizing the need for physical interaction and simplifying the parking process, Stanley Robotics aims to transform the way customers manage their parking needs.

Qynapse

Venture Round in 2015
Qynapse is a technology company focused on enhancing the screening and monitoring of Central Nervous System (CNS) diseases through the integration of MRI scans and artificial intelligence. Headquartered in France, the United States, and Canada, Qynapse develops cloud-based quantitative imaging software that aims to revolutionize patient care by optimizing diagnosis, prognosis, and longitudinal monitoring for conditions such as Alzheimer's and other neurological disorders. By providing rapid and actionable insights, the company enables healthcare professionals to perform accurate and efficient assessments of therapy efficacy, ultimately improving patient selection and treatment evaluation in both clinical routine settings and clinical trials.

WIT France

Venture Round in 2015
WIT France SAS, established in 2006 and headquartered in Blanquefort near Bordeaux, specializes in manufacturing glass tube containers designed for the storage and presentation of wines and spirits in individual formats. Founded by an oenologist and a sommelier, the company leverages several technological innovations to ensure that its products maintain the quality and preservation of traditional bottles while catering to the needs of both professionals and consumers. WIT France's offerings are utilized in various commercial sectors, including showrooms, wine shops, trade shows, hotels, and restaurants, and serve marketing purposes for importers, salesmen, and corporate gifts. The company operates both nationally and internationally, providing a unique packaging solution for the wine industry.

LOMA Innovation

Venture Round in 2015
LOMA Innovation, based in Paris, France, is a startup that specializes in developing a unique electroformable composite technology. This patented process allows for the creation of deformable and reshapable materials suitable for various everyday products, including massage objects, paramedical splints, headrests for transport vehicles, ski boots, and toys. LOMA Innovation aims to enhance the customer experience by offering customizable materials that can be modified rapidly and reversibly. By focusing on sustainability, the company is positioned to revolutionize the thermoplastics industry, providing innovative solutions that cater to a diverse range of applications.

Lifen

Seed Round in 2015
Lifen, a 160-employee Paris-based startup, specializes in streamlining medical data communication. Founded in 2015, it has become France's leading MSSanté operator, serving over 600 healthcare establishments and facilitating monthly exchanges of 2 million medical documents among 240,000 doctors. Lifen's platform simplifies data sharing through secure email, reducing paper mail and automating communication mode identification. Recognized for its interoperability expertise, Lifen aims to develop a platform that eases integration and deployment of digital solutions in healthcare.

Orosound

Venture Round in 2015
Orosound is a French startup focused on enhancing workplace well-being through innovative Noise Control Technologies. The company designs and manufactures high-tech audio earphones under the brand Tilde, which feature advanced noise-filtering technology. This technology allows users, particularly office workers, to selectively filter out distracting ambient noise, thereby improving concentration and productivity in their work environments. Orosound's commitment to developing acoustic products aims to enhance the daily lives of individuals by providing effective solutions for noise management.

Rogervoice

Venture Round in 2015
Rogervoice, established in 2013 and headquartered in Paris, France, specializes in developing assistive communication technologies. Its flagship product is a smartphone application that facilitates real-time, automatic transcription of phone calls into multiple languages, enabling deaf or hard-of-hearing individuals to participate in conversations more effectively.

Oregon Therapeutics

Venture Round in 2015
Oregon Therapeutics is a biotechnology company focused on developing innovative anti-cancer therapies, particularly through its lead candidate, XCE853. This drug represents a novel approach in oncology, utilizing a unique mechanism of action that inhibits protein disulfide isomerase. The company aims to advance XCE853 into clinical trials within two years to address metabolic vulnerabilities in certain cancers. Its primary focus is on treating ovarian cancer and advanced pancreatic cancer. By targeting specific enzymes involved in cell metabolism, Oregon Therapeutics is dedicated to providing effective treatment options for cancer patients, with a commitment to improving outcomes in this challenging therapeutic area.

Eligo Bioscience

Venture Round in 2015
Eligo Bioscience S.A.S is a biotechnology company founded in 2014 and based in Paris, France, specializing in the development of Eligobiotics, a novel class of antimicrobials. These therapeutics are designed to target specific bacteria based on their genomic information, utilizing a combination of CRISPR/Cas technology and engineered phage capsids. This advanced approach allows Eligo to create precision antibiotics aimed at eradicating resistant pathogens and virulent bacteria within the human microbiome. The applications of Eligobiotics extend beyond pharmaceuticals; they also encompass areas such as cosmetics and biodefense, addressing a variety of bacteria-associated diseases and offering next-generation solutions to combat superbugs.

Step Pharma

Seed Round in 2014
Step Pharma, incorporated in 2014 and based in Paris, France, focuses on developing innovative drugs for immunosuppressive therapies aimed at treating autoimmune diseases. As a spin-off of the Imagine Institute, the company emerged from research led by Pr. Alain Fischer on genetic immunodeficiencies. It operates as a joint venture with Sygnature Discovery, which provides integrated drug discovery resources, and Kurma Partners, a prominent investor in European healthcare and biotechnology. Step Pharma's proprietary small molecule therapeutics utilize a novel class of oral nucleotide synthesis inhibitors that target cytidine triphosphate synthase 1. This approach allows for the selective modulation of immune cell populations, such as T and B cells, enhancing treatment efficacy and therapeutic outcomes for patients with autoimmune conditions.

Plume Labs

Venture Round in 2014
Plume Labs, established in 2014 and headquartered in Paris, France, specializes in air quality monitoring and personal exposure tracking. The company produces a wearable air sensor and a mobile application, Air Report, which provides real-time pollution forecasts and personalized recommendations to users in over 150 cities worldwide. Plume Labs' technology empowers individuals to plan their activities and reduce exposure to air pollution, while its data platform, Air Cloud, enables businesses and decision-makers to access and analyze air quality data.

DAMAE Medical

Venture Round in 2014
DAMAE Medical, established in 2014 and headquartered in Paris, France, specializes in developing innovative medical devices for dermatological applications. The company's flagship product, OCTAV, employs advanced optical imaging technology to provide dermatologists with high-resolution, in-depth images of skin tissue, similar to traditional histology, but without the need for tissue excision or processing. This non-invasive, in-vivo imaging modality enables precise, efficient, and rapid evaluation of skin tumors, aiding in the diagnosis of skin cancers. DAMAE Medical's mission is to harness the power of bio-photonics to revolutionize medical imaging and diagnosis in dermatology.

OncoDiag

Venture Round in 2014
OncoDiag is a biotechnology company based in Normandy, France, specializing in the development of non-invasive diagnostic tests aimed at the early detection of cancers. Its flagship product, Urotest, is a urine test designed for the diagnosis and monitoring of bladder cancer. Additionally, the company is advancing its pipeline with Colodiag, which focuses on the early detection of colorectal cancer. OncoDiag's portfolio also includes a tissue-based test for predicting non-evolutive localized prostate cancer. By offering these innovative diagnostic solutions, OncoDiag aims to enhance the capabilities of healthcare professionals in cancer diagnosis and management.

Biomunex Pharmaceuticals

Venture Round in 2014
Biomunex Pharmaceuticals is a French biopharmaceutical company established in 2014 in Paris, dedicated to the discovery and development of innovative bispecific antibody therapeutics aimed at addressing unmet medical needs, particularly in oncology. Utilizing its proprietary BiXAb platform, Biomunex specializes in creating modular bispecific antibodies that exhibit high anti-tumor potential and optimal manufacturability. The company is focused on developing advanced immunotherapies for various cancer types, with its leading candidate, BMX-002, showing promising efficacy in treating pancreatic cancer and potential in other solid tumors such as head and neck, gastric, and colon cancers. Additionally, BMX-101, the second lead candidate, targets multiple myeloma and other hematological malignancies through immune checkpoint inhibition. Biomunex collaborates with prestigious academic institutions to advance its research programs, supported by a management team of experienced professionals from the pharmaceutical and biotech sectors, with a strong background in oncology.

Soundsgood

Venture Round in 2014
Soundsgood is a platform designed to empower music influencers by offering innovative playlist curation services across all music platforms. Established in France in November 2014, the company has successfully connected over 3,900 leading influencers in local culture and music with their audiences. By allowing influencers to create and share universal playlists, Soundsgood enables them to reach millions of followers and enhance their visibility on various music platforms and social networks. The company's goal is to serve as a comprehensive resource for music influencers seeking to expand their audience and promote their musical tastes. With its services now available worldwide, Soundsgood continues to facilitate the sharing of music and the growth of its user base.

Aenitis Technologies

Venture Round in 2013
Aenitis Technologies is a French start-up founded in July 2014 by researchers Mauricio Hoyos and Jean-Luc Aider from the CNRS. The company specializes in the development of innovative medical devices that address challenges in cell therapy preparation and bioprocessing. Aenitis Technologies focuses on solutions for cell sorting, washing, and isolation, utilizing acoustophoresis technologies to enhance the efficiency of these processes. With an emphasis on revolutionizing practices in public health, Aenitis Technologies aims to establish itself as a world leader in the separation and filtration of biological elements, providing vital support to cell therapy units and blood banks in the healthcare industry.

Niland

Venture Round in 2013
Niland is a music technology start-up founded in 2013 and headquartered in Paris. The company specializes in music search and recommendation engines, utilizing advanced machine learning techniques to analyze acoustic signals and extract meaningful data from audio tracks. Niland's technology addresses common challenges in music search and discovery by automatically identifying musical and emotional characteristics, enabling the creation of personalized playlists and tailored music recommendations for various applications, such as film and advertising. The company's innovative approach has been recognized for its effectiveness, having won the MIREX 2011 competition and maintaining its status as a leader in the field since then. Niland's mission is to connect the right songs with the right users at the right time, facilitating enhanced customer engagement for music companies.

Openergy

Venture Round in 2013
Openergy is a company based in Boulogne Billancourt, France, that specializes in developing a software platform aimed at enhancing energy efficiency in the building retrofitting sector. Founded in 2012, Openergy's platform provides tools for monitoring and verifying energy performance throughout the lifecycle of buildings, from design to operation. It employs big data analysis and energy simulation to identify discrepancies between theoretical and actual energy performance. The company's offerings include optimized energy audits, validation of modeling based on historical data, risk assessments for safety margins, and comprehensive measurement and verification plans. Additionally, Openergy facilitates automated data management, contractual monitoring, performance tracking, and reporting, thereby widening access to retrofitting initiatives and enabling operators to adapt to climate change more effectively.

Doctolib

Pre Seed Round in 2013
Doctolib is an online healthcare booking platform and management software provider based in Paris, France, founded in 2013. The company offers a comprehensive service for healthcare practitioners, enabling them to manage appointments, reduce no-shows, and attract new patients. For patients, Doctolib provides a free and user-friendly online service that allows individuals to easily find local health practitioners and book appointments for medical or dental consultations at any time. By streamlining the appointment process, Doctolib enhances access to healthcare services for both professionals and patients, facilitating better management of consultations and patient interactions.

Cryptosense

Seed Round in 2013
Cryptosense SA is a company specializing in automated analysis solutions for cryptographic systems, headquartered in Paris, France. Established in 2013, it offers several products designed to enhance cryptographic security. Its flagship tool, Cryptosense Analyzer, conducts vulnerability assessments of cryptographic interfaces, adapting its attack strategies based on the behavior of the device being tested. Additionally, Cryptosense provides tools such as Cryptosense App Tracer for identifying common cryptographic mistakes and key management errors, Cryptosense Monitor for comparison and alerting, and Cryptosense Simulator for replicating Hardware Security Module (HSM) behavior. The company's software is utilized by a diverse clientele, including technology firms, payment system operators, banks, and secure hardware and software manufacturers, all of whom rely on its solutions to protect sensitive data and mitigate security risks in their cryptographic infrastructures. Cryptosense's innovative approach is supported by ongoing research and development, ensuring that its tools remain effective against emerging vulnerabilities.

legalstart.fr

Venture Round in 2013
Legalstart.fr is an automatic generation Internet platform that manages legal documents and links with lawyers. The company offers two types of services, legalstart.fr allows users to simply make quality legal documents and the company puts users in touch with a lawyer adapted to a situation. With Legalstart, users can make and manage a business, recruit an employee, register a trademark, hire a home help or terminate a dispute. Users can have access to a quality and cost-effective solution to meet all of the legal needs. Legalstart.fr was founded on 2013 and is based in Paris, France.

Dataiku

Seed Round in 2013
Dataiku Inc. is a data platform company that specializes in artificial intelligence and machine learning, facilitating businesses in their data journey from analytics to enterprise AI. Founded in 2013 and headquartered in New York, with additional offices in Paris and London, Dataiku develops the Dataiku DSS, a collaborative software platform designed for data scientists, analysts, and engineers. This platform enables users to prepare, analyze, and visualize data, allowing for interactive exploration and the application of machine learning technologies through a user-friendly interface. By providing a centralized environment that fosters collaboration and best practices, Dataiku aids organizations in overcoming challenges in data management and deployment, leading to more efficient and impactful data-driven solutions. Notable clients include Unilever, GE, and FOX News Group, who leverage Dataiku to accelerate their data initiatives and enhance their operational capabilities.

Skintifique

Venture Round in 2012
Skintifique is a derma-tech company focused on developing innovative skincare solutions for individuals with sensitive or reactive skin. The company offers a diverse range of products, including lotions, creams, cleanser gels, hydrating gels, and anti-pollution packs, all designed to meet the specific needs of customers with skin sensitivities. Skintifique's formulations are characterized by their efficacy and clean ingredient profiles, utilizing proprietary, patented technologies. The company primarily sells its products directly to consumers through its websites and digital channels, with its largest markets located in the USA, France, and the UK. Founded by Dr. Jacques Delort and Professor Jeff Karp, Skintifique has assembled a talented team of professionals to advance its mission of enhancing the well-being of those with skin concerns.

Cailabs

Venture Round in 2012
CAILabs SAS is a French deep tech company headquartered in Rennes, specializing in the design, development, and production of photonic solutions aimed at optimizing light utilization in various applications. Established in 2013, CAILabs focuses on innovative optical components, particularly through its patented Multi-Plane Light Conversion (MPLC) technology. The company provides a range of products, including mode multiplexers, light converters, and laser beam shaping solutions tailored for the telecommunications and industrial laser sectors. Its offerings are designed to enhance the performance of fiber optic networks and laser material processing, addressing critical challenges such as atmospheric turbulence and the need for efficient signal multiplexing. CAILabs aims to leverage its expertise and technological innovations to create reliable and cost-effective solutions for clients in the photonics industry.

PayPlug

Angel Round in 2012
PayPlug SAS is an online payment solution provider based in Paris, France, founded in 2012. It is designed specifically for small and medium-sized enterprises (SMEs) and micro-businesses, enabling them to sell goods and services online effortlessly. The platform allows users to create a payment page by entering transaction details, which can then be shared via a ‘pay’ button on their website or through direct links sent via email or SMS. This streamlined approach facilitates secure payments and provides users with email notifications upon transaction completion. PayPlug serves a diverse range of clients, including B&Bs, photographers, consultants, non-profits, and online stores. As of April 2017, PayPlug operates as a subsidiary of Natixis S.A., enhancing its capabilities through partnerships with local banks to improve payment acceptance and fraud risk management.

Phonotonic

Venture Round in 2012
Phonotonic is a Paris-based startup founded in 2011, composed of a diverse team of musicians, designers, engineers, and researchers. The company emerged from a decade of research at IRCAM, a leading institution in music and sound technology. Phonotonic aims to democratize music creation by developing innovative applications and hardware that allow users to compose and perform live music through movement. Their flagship product includes a wearable device that uses inertial sensors to track movements and communicate with software via Bluetooth, enabling real-time music creation and control. Recognized for its technological advancements, Phonotonic has received accolades such as the 1st prize at the Guthman Competition and has been showcased at the Museum of Modern Art in New York City. The company seeks to transform the music experience for both expert musicians and a broader audience.

GenSight Biologics

Venture Round in 2012
GenSight Biologics S.A. is a clinical-stage biotechnology company based in Paris, France, focused on the discovery and development of gene therapies for retinal degenerative diseases and neurodegenerative disorders of the central nervous system. Founded in 2012, the company utilizes innovative technologies, including mitochondrial targeting sequences and optogenetics, to develop treatments that aim to preserve or restore vision in patients with severe vision impairments. Its lead product candidates include GS010, an AAV2-based gene therapy that is currently undergoing Phase III clinical trials for Leber hereditary optic neuropathy caused by mutations in the ND4 gene, and GS030, which is in Phase I/II trials for retinitis pigmentosa and geographic atrophy associated with dry age-related macular degeneration. GenSight Biologics is also advancing other product candidates in preclinical development targeting various ophthalmic and neurodegenerative conditions.

Infinit

Venture Round in 2012
Infinit International, founded in 2012 by Julien Quintard and Baptiste Fradin, is a technology company that focuses on simplifying file sharing. The company gained recognition for its innovative approach, graduating from Le Camping’s accelerator program in Paris and earning accolades from various innovation contests, including the Qualcomm QPrize and the French National Innovation Contest. In 2014, Infinit further advanced its development by participating in the Techstars accelerator program in New York City. The company successfully secured $1.8 million in funding from Alven Capital and 360 Capital Partners, which has helped bolster its mission to enhance the user experience in digital file transmission.

Ynsect

Venture Round in 2012
Ynsect is a biotechnology company based in Evry, France, that specializes in the production and processing of insects for sustainable animal feed and non-food applications. Founded in 2011, Ynsect operates insect vertical farms that convert insects into high-quality nutrition products, including proteins and lipids for livestock and pet diets. The company employs innovative bioconversion techniques to utilize organic resources, producing not only animal feed but also organic fertilizers, bioenergy, and other valuable materials. Ynsect's expertise in large-scale insect farming and automation has positioned it as a leading provider in the agro-food and environmental biotech sectors, making it a favored partner for agricultural professionals, research institutions, and investors.

Pixium Vision

Venture Round in 2012
Pixium Vision SA is a bioelectronics company based in Paris, France, focused on developing innovative implantable medical devices aimed at restoring vision for individuals blinded by the degeneration of photoreceptor cells in the retina. The company’s flagship product, the PRIMA System, is a bionic vision system designed to improve visual acuity and enhance the independence of patients. Pixium Vision also works on the Intelligent Retinal Implantable System (IRIS1), which is currently undergoing clinical trials, and is developing two subsequent generations, IRIS2 and IRIS3, each designed to provide improved visual capabilities through advanced technologies. Founded in 2011 as a spin-out from the Vision Institute and Université Pierre et Marie Curie, Pixium collaborates with prestigious institutions such as Stanford University and Moorfields Eye Hospital to further its research and development efforts in retinal implant systems.

Precogs

Venture Round in 2012
Precogs is a business analytics company based in Paris, France, founded in 2011. It specializes in providing solutions for supply risk management, enterprise resource planning, and procurement monitoring. The company offers innovative products such as CogWatch, a big data predictive tool designed for analytics, and Cog Margin, a component pricing platform. Precogs focuses on serving EMS-ODM-OEM businesses by delivering real-time information on the best available prices for electronic components, enhancing their decision-making processes and operational efficiency.

AdQuantic

Venture Round in 2011
AdQuantic is a company that specializes in enhancing the performance of Search Engine Marketing (SEM) campaigns through advanced optimization tools. Founded by two doctors in statistical physics, the company utilizes methods rooted in this discipline, incorporating elements of game theory to inform its bid management strategies. AdQuantic's tools are designed to be adaptable, featuring functionalities that account for factors such as seasonality, thereby allowing for more precise campaign adjustments. Headquartered in Paris, the company is dedicated to providing tailored solutions that improve the effectiveness of advertising services.

Point Vision Group

Venture Round in 2011
Point Vision Group offers patients the possibility of making appointments in a very short time, mainly through an internet platform. It is the first group to respond on a large scale to the lack of ophthalmologists in France that generates average wait times of three months for an appointment. Point Vision industrialized the consultation process by segmenting the different stages and delegating non-medical tasks to technicians.

Open Ocean

Venture Round in 2011
Open Ocean SAS is a French company, established in 2011 and operating out of Brest and Paris, that specializes in developing SaaS-based decision-making platforms for offshore infrastructure and marine operations. The company offers a range of innovative solutions, including the Metocean Analytics tool, which analyzes atmospheric and oceanic conditions, and provides comprehensive reports on tidal energy markets in France. Additionally, Open Ocean produces a spectral wave database to support the development of marine renewable energy in Scotland. Their services include site data analysis, resource and energy assessment, environmental impact assessments, and adherence to greenhouse gas protocols for wave and tidal energy projects. Open Ocean's highly qualified team of oceanographers, trained at leading research institutions, focuses on high-resolution modeling, statistical analysis, and data mining, catering to farm developers, operators, and public agencies in the renewable marine energy sector. As of September 2019, Open Ocean operates as a subsidiary of Artelia SAS.

Nanobacterie

Venture Round in 2011
Nanobacterie, founded in 2008, is a pioneering company specializing in the medical applications of magnetic nanoparticles derived from magnetotactic bacteria, known as magnetosomes. The company has developed a novel cancer treatment called magnetic hyperthermia, where these magnetosomes are introduced into tumors and heated using an alternating magnetic field, thereby inducing antitumor activity. Unlike chemically synthesized nanoparticles, magnetosomes offer superior heating properties due to their larger size and chain arrangement, resulting in more uniform heating. Nanobacterie has successfully conducted proof-of-concept studies in mouse models for breast cancer and glioblastoma, achieving complete tumor eradication in glioblastoma cases. The company aims to initiate clinical trials for this treatment, focusing on incurable cancers like glioblastoma, contingent upon meeting regulatory safety standards and manufacturing requirements. With a small team of five, Nanobacterie collaborates closely with academic partners, including a medical team at Pitié Salpêtrière Hospital, and operates within the Orsay/Paris-Sud University campus.

Blue Industry & Science

Venture Round in 2010
Blue Industry & Science, established in 2010 and headquartered in Paris, France, specializes in the manufacture and distribution of advanced monitoring instruments. The company's core products include field gas analyzers, designed for industrial process control and indoor air quality monitoring. Utilizing tunable laser technology, these instruments can detect trace amounts of various gases in real-time, ensuring compliance with regulations and maintaining safe working environments.

Acticor Biotech

Venture Round in 2010
Acticor Biotech SAS is a clinical-stage biopharmaceutical company based in Paris, France, founded in 2013. The company specializes in developing innovative therapeutic monoclonal antibodies aimed at treating acute thrombotic diseases, particularly focusing on acute ischemic stroke. Its lead product, Glenzocimab, is a humanized antibody designed to address the critical need for new therapeutic options in the management of stroke, a condition that affects millions globally each year and leads to significant mortality and disability. Currently, existing treatments for ischemic stroke have limited efficacy and reach, highlighting the urgent demand for more effective solutions. Acticor Biotech is dedicated to advancing its novel therapies to meet this pressing medical need.

G2Mobility

Venture Round in 2010
G2Mobility, founded in 2009 and based in Paris, France, specializes in smart charging solutions for electric vehicles. The company provides a range of charging infrastructure products and services designed to enable users to effectively manage networks of charge points from a single platform. G2Mobility's offerings include a variety of electric vehicle charging stations and energy management systems, aimed at enhancing the efficiency and accessibility of electric vehicle charging.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.